Pancreatic Cancer Research

ResearcherKumamoto UniversityNo recent work listed

Hiroshi Takamori

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4070-1242; OpenAlex author ID A5101822724. Sources: OpenAlex.

Their work

Papers
8 (first author 2, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
40
Papers, trials and grants by year

2011: 2 papers · 2012: 1 paper · 2013: none · 2014: 1 paper · 2015: 1 paper · 2016: none · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 8

  1. Effect of duration of adjuvant chemotherapy with S-1 (6 versus 12 months) for resected pancreatic cancer: the multicenter clinical randomized phase II postoper… Co-author DOI 10.1007/s10147-023-02399-7↗
  2. Conversion surgery for initially unresectable pancreatic ductal adenocarcinoma with synchronous liver metastasis after treatment with FOLFIRINOX. Last author DOI 10.1007/s12328-019-00965-z↗
  3. Preoperative High Maximum Standardized Uptake Value in Association with Glucose Transporter 1 Predicts Poor Prognosis in Pancreatic Cancer. Co-author DOI 10.1245/s10434-017-5799-1↗
  4. Impact of Postoperative Weight Loss on Survival After Resection for Pancreatic Cancer. Co-author DOI 10.1177/0148607114520992↗
  5. Influence of preoperative anti-cancer therapy on resectability and perioperative outcomes in patients with pancreatic cancer: project study by the Japanese Soc… Co-author DOI 10.1002/jhbp.15↗
  6. An autopsy study to clarify characteristics of local recurrence after extended pancreatectomy with intraoperative radiation therapy in patients with pancreatic… First author DOI 10.1007/s00423-012-0934-8↗
  7. Sister Mary Joseph's nodule derived from pancreatic cancer. First author DOI 10.1007/s00534-010-0296-y↗
  8. Perioperative intra-arterial and systemic chemotherapy for pancreatic cancer. Co-author DOI 10.1245/s10434-010-1384-6↗

Closest collaborators

The 25 strongest of 40 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hideo Baba · 5 shared papers, 2011–2023 · strength 0.36
  2. Hiromitsu Hayashi · 2 shared papers, 2019–2023 · strength 0.24
  3. Akira Chikamoto · 3 shared papers, 2012–2017 · strength 0.15
  4. Tohru Utsunomiya · 1 shared paper, 2023 · strength 0.15
  5. Mototsugu Shimokawa · 1 shared paper, 2023 · strength 0.15
  6. Keishi Sugimachi · 1 shared paper, 2023 · strength 0.15
  7. Tomoharu Yoshizumi · 1 shared paper, 2023 · strength 0.15
  8. Kenichiro Araki · 1 shared paper, 2023 · strength 0.15
  9. Tadashi Uwagawa · 1 shared paper, 2023 · strength 0.15
  10. Shinji Itoh · 1 shared paper, 2023 · strength 0.15
  11. Hiroto Kayashima · 1 shared paper, 2023 · strength 0.15
  12. Daisuke Hashimoto · 2 shared papers, 2015–2017 · strength 0.11
  13. Ozaki Kentaro · 1 shared paper, 2019 · strength 0.09
  14. Toshiro Masuda · 1 shared paper, 2019 · strength 0.09
  15. Yasuyuki Yamashita · 2 shared papers, 2011–2017 · strength 0.09
  16. Masahiko Hirota · 2 shared papers, 2011–2015 · strength 0.08
  17. Hideo Baba · 2 shared papers, 2011–2012 · strength 0.06
  18. Takeharu Yamanaka · 1 shared paper, 2017 · strength 0.06
  19. Hideo Baba · 1 shared paper, 2017 · strength 0.06
  20. Shigeki Nakagawa · 1 shared paper, 2015 · strength 0.05
  21. Nobuyuki Ozaki · 1 shared paper, 2011 · strength 0.04
  22. Hiroshi Tanaka · 1 shared paper, 2012 · strength 0.04
  23. Tomoo Kosuge · 1 shared paper, 2014 · strength 0.03
  24. Keita Wada · 1 shared paper, 2014 · strength 0.03
  25. Takaho Okada · 1 shared paper, 2014 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.